DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Bottcher S, Ritgen M, Fischer K. et al.
Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.
J Clin Oncol 2012;
30: 980-988
We do not assume any responsibility for the contents of the web pages of other providers.